Hyperrab 300 unit/ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9L74
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,350
Award facts
- Contract value 100% obligated
- $19,350.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,350.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5ML units) on December 4, 2025, with an ultimate completion date of December 26, 2025. The award represents a non-competitive, non-set-aside delivery order executed at the vendor's place of performance in Conshohocken, Pennsylvania. This order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical commodities including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for rabies immunoglobulin products reflects the vendor's ongoing role in supporting military medical supply chain requirements through competitive, firm fixed-price transactions with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F9L74?
SPE2DR26F9L74 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F9L74 worth?
The government has obligated $19,350 on SPE2DR26F9L74.
Is contract SPE2DR26F9L74 an order under another contract?
Yes. SPE2DR26F9L74 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9L74 competed?
The extent of competition for SPE2DR26F9L74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award